bmy 45778 has been researched along with alprostadil in 1 studies
Studies (bmy 45778) | Trials (bmy 45778) | Recent Studies (post-2010) (bmy 45778) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
---|---|---|---|---|---|
16 | 0 | 4 | 7,136 | 864 | 761 |
Protein | Taxonomy | bmy 45778 (IC50) | alprostadil (IC50) |
---|---|---|---|
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chow, KB; Wise, H; Wong, YH | 1 |
1 other study(ies) available for bmy 45778 and alprostadil
Article | Year |
---|---|
Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.
Topics: Acetates; Adenylyl Cyclases; Alprostadil; Animals; Cell Survival; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Iloprost; Imidazoles; Inositol Phosphates; Oxazoles; Phenoxyacetates; Pyridines; Receptors, Epoprostenol; Receptors, Prostaglandin; Transfection; Tritium; Type C Phospholipases | 2001 |